Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Werewolf Therapeutics, Inc. (HOWL) had Weighted-Average Shares Outstanding (Diluted) of 45.80M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-16.37M |
|
-- |
|
-- |
|
$15.73M |
|
$-15.73M |
|
$-0.64M |
|
$-16.37M |
|
$-16.37M |
|
$-16.37M |
|
$-16.37M |
|
$-16.37M |
|
$-16.37M |
|
$-15.73M |
|
$-15.32M |
|
45.80M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
45.80M |
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$68.17M |
|
$5.09M |
|
$11.45M |
|
$79.63M |
|
$17.60M |
|
$21.66M |
|
$32.41M |
|
$50.01M |
|
$29.61M |
|
$29.61M |
|
$29.61M |
|
47.27M |
|
| Cash Flow Statement Financials | |
$-49.27M |
|
$0.00M |
|
$3.66M |
|
$112.22M |
|
$66.61M |
|
$-45.61M |
|
$5.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.87 |
|
-- |
|
-- |
|
0.42 |
|
0.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-55.28% |
|
-55.28% |
|
-20.56% |
|
-31.93% |
|
$0.63 |
|
$-1.08 |
|
$-1.08 |
|